Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies
Completed
- Conditions
- Multiple Sclerosis
- Registration Number
- NCT01020370
- Lead Sponsor
- Wayne State University
- Brief Summary
The primary goal of this study will be to explore the reparative and regenerative potential of alemtuzumab in RRMS patients who are participating in the CARE MS I and CARE MS II studies using conventional and non-conventional MRI sequences.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Participating in either the CARE MS I or CARE MS II studies
Exclusion Criteria
- Not a participant in the CARE MS I or CARE MS II studies
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Explore the reparative and regenerative potential of alemtuzumab in RRMS patients who are participating in the CARE MS I and CARE MS II studies
- Secondary Outcome Measures
Name Time Method Compare the effect of alemtuzumab to interferon beta-1a SC on non-conventional MRI outcomes